Clinical Trial Update: Effect of Botulinum Toxin Injection Into Upper Esophageal Sphincter in Patients With Medullary Infarction [NA]

View source ↗

Summary

A clinical trial evaluating injection of botulinum toxin into the upper esophageal sphincter for dysphagia due to brain stem infarction is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Stem Infarction
• Esophageal Dysphagia
• Oropharyngeal Dysphagia

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: The First Affiliated Hospital of Zhengzhou University | Conditions: Brain Stem Infarctions, Dysphagia, Oropharyngeal | NA | Status: RECRUITING